Dr. Marek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1901 S 2nd St
McAllen, TX 78503Phone+1 956-687-5150Fax+1 956-687-9546
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1986 - 1988
University of Kentucky College of MedicineResidency, Internal Medicine, 1984 - 1986- University of Kentucky College of MedicineInternship, Internal Medicine, 1983 - 1984
The University of Texas Health Science Center at San AntonioClass of 1983
Certifications & Licensure
TX State Medical License 1988 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Board of Directors Rio Grande Regional Hospital, 2012
- Board of Directors Texas Oncology, 2012
- Regional Medical Director Texas Oncology, 2012
- Join now to see all
Clinical Trials
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
- Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant Start of enrollment: 2011 Apr 20
- A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation Start of enrollment: 2013 Aug 12
- Join now to see all
Publications & Presentations
PubMed
- 38 citationsRelation between chelation and clinical outcomes in lower-risk patients with myelodysplastic syndromes: Registry analysis at 5 years.Roger M. Lyons, Billie J. Marek, Carole Paley, Jason Esposito, Katie McNamara
Leukemia Research. 2017-05-01 - 38 citationsComparison of 24-month outcomes in chelated and non-chelated lower-risk patients with myelodysplastic syndromes in a prospective registryRoger M. Lyons, Billie J. Marek, Carole Paley, Jason Esposito, Lawrence E. Garbo
Leukemia Research. 2014-02-01
Press Mentions
Trending: Vaccines for Cancer Prevention & TreatmentFebruary 21st, 2018- Texas Oncology Expands in Rio Grande Valley to Provide Surgical Oncology ServicesSeptember 15th, 2023
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
